Why the study?
Does chronic verapamil treatment prevent the progression of coronary sclerosis in patients with coronary artery disease?
Does chronic verapamil treatment prevent the progression of coronary sclerosis in patients with coronary artery disease?
Retrospective data suggests that chronic verapamil treatment may slow the progression of coronary sclerosis, though confirmation from prospective trials is required.
No takes yet. Share an insight, caveat, or question.
Should not change practice in CAD; retrospective data leaves open verapamil slowing coronary sclerosis, needing prospective trials.
Kober et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: